Urology · Tallahassee, FL
NPI
1740243526
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2000 Centre Pointe Blvd
Tallahassee, FL, 32308
Phone (850) 309-0400
Groups this clinician bills Medicare through
Medicare paid, 2024
$178K
16,188 services
Medicare patients, 2024
522
Average age 78
Drug cost, 2024
$10.3M
2,148 prescriptions
Company payments, 2025
$466K
From 27 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott B Sellinger was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 1,500 times for 15 patients. In total Scott B Sellinger billed 16,188 services in 75 codes, and Medicare paid $178K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,500 | 15 | $0.10 | $148 |
| J0897 Injection, denosumab, 1 mg | Office | 1,141 | 13 | $20.45 | $23K |
| 99214 Office E&M - Established | Office | 492 | 341 | $96.89 | $48K |
| 81003 Clinical Chemistry | Office | 397 | 314 | $2.18 | $865 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 259 | 214 | $12.66 | $3,278 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 249 | 45 | $50.61 | $13K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 211 | 33 | $139.28 | $29K |
| 36415 Venipuncture Blood Collection | Office | 196 | 144 | $7.04 | $1,380 |
| 99213 Office E&M - Established | Office | 105 | 96 | $70.27 | $7,378 |
| 96402 Chemotherapy Administration | Office | 67 | 41 | $27.42 | $1,837 |
| 96372 Injection Administration | Office | 66 | 42 | $11.33 | $748 |
| 51798 Ultrasound - Nonspecific | Office | 56 | 51 | $8.95 | $501 |
| 74018 Standard X-ray | Office | 52 | 50 | $22.41 | $1,166 |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 42 | 22 | $1.95 | $82.06 |
| 51702 Other Organ Systems | Office | 34 | 16 | $49.84 | $1,695 |
By year: 2022 $207K for 14,311 services; 2023 $232K for 16,067 services; 2024 $178K for 16,188 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 397 | 314 | $2.18 | $865 |
| 36415 Venipuncture Blood Collection | 196 | 144 | $7.04 | $1,380 |
| 81002 Clinical Chemistry | 20 | 18 | $3.41 | $68.2 |
Medicare prescription drug claims, 2024
In 2024, the drug Scott B Sellinger prescribed most often to Medicare patients was Erleada (Apalutamide), with 356 prescriptions and refills. In total Scott B Sellinger wrote 2,148 Medicare prescriptions that cost $10.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Erleada Apalutamide | 356 | 360 | 48 | $5.1M |
| Tamsulosin Hcl Generic | 326 | 805 | 93 | $4,491 |
| Xtandi Enzalutamide | 284 | 284 | 31 | $3.9M |
| Finasteride Generic | 180 | 510 | 53 | $3,016 |
| Myrbetriq Mirabegron | 136 | 233 | 39 | $100K |
| Ciprofloxacin Hcl Generic | 86 | 86 | 65 | $377 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 82 | 220 | 22 | $1,946 |
| Nubeqa Darolutamide | 63 | 63 | Under 11 | $850K |
| Abiraterone Acetate Generic | 45 | 45 | Under 11 | $81K |
| Cephalexin Generic | 44 | 121 | 20 | $589 |
| Dutasteride Generic | 41 | 99 | Under 11 | $851 |
| Silodosin Generic | 40 | 110 | 15 | $4,050 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 36 | 84 | 17 | $2,609 |
| Gemtesa Vibegron | 35 | 57 | 11 | $26K |
| Prednisone Generic | 34 | 42 | Under 11 | $327 |
Brand drugs: 913 claims; generic drugs: 1,235 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott B Sellinger $466K ($466K in general payments such as food, travel and fees) from 27 companies. The largest payer was Janssen Biotech, Inc. with $112K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 134 | $112K |
| AstraZeneca Pharmaceuticals LP AZN | 71 | $83K |
| Astellas Pharma US Inc 4503.T | 53 | $73K |
| Pfizer Inc. PFE | 51 | $49K |
| Sumitomo Pharma America, Inc. 4506.T | 31 | $42K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 33 | $35K |
| Accord Healthcare, Inc. | 33 | $34K |
| Avyxa Pharma, LLC | 13 | $16K |
| Janssen Scientific Affairs, LLC JNJ | 2 | $9,600 |
| Janssen Pharmaceuticals, Inc JNJ | 4 | $4,881 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.